标题
Inhibition of the renin–angiotensin–aldosterone system
作者
关键词
-
出版物
JOURNAL OF HYPERTENSION
Volume 30, Issue 4, Pages 647-654
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2012-01-21
DOI
10.1097/hjh.0b013e32834f6e00
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
- (2013) Regina Kunz et al. ANNALS OF INTERNAL MEDICINE
- Redefining Blood Pressure Targets in High-Risk Patients?: Lessons From Coronary Endpoints in Recent Randomized Clinical Trials
- (2011) M. Volpe et al. AMERICAN JOURNAL OF HYPERTENSION
- Renal function and target organ damage in hypertension
- (2011) L. M. Ruilope et al. EUROPEAN HEART JOURNAL
- Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease
- (2011) R. E. Schmieder et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aldosterone and cardiovascular disease
- (2011) Robert M Carey Current Opinion in Endocrinology Diabetes and Obesity
- Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility
- (2011) Lanqi Jia et al. ACS Medicinal Chemistry Letters
- Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve
- (2010) A. Zanchetti EUROPEAN HEART JOURNAL
- DUAL INHIBITION OF CLASSICAL PKC-ALPHA AND PKC-BETA-ISOFORMS IN A PHARMACOLOGICAL AND DOUBLE KNOCK-OUT MOUSE APPROACH LEADS TO PROTECTION AGAINST DIABETIC NEPHROPATHY: 5A.04
- (2010) J Menne et al. JOURNAL OF HYPERTENSION
- Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])
- (2009) Brett R. Cowan et al. AMERICAN JOURNAL OF CARDIOLOGY
- Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)
- (2009) L. F. Fried et al. Clinical Journal of the American Society of Nephrology
- Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2009) S. D. Navaneethan et al. Clinical Journal of the American Society of Nephrology
- Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?
- (2009) Alberto Zanchetti JOURNAL OF HYPERTENSION
- Aldosterone-receptor antagonism in hypertension
- (2009) Pieter M Jansen et al. JOURNAL OF HYPERTENSION
- Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
- (2009) Giuseppe Mancia et al. JOURNAL OF HYPERTENSION
- The Kidney, Hypertension, and Remaining Challenges
- (2009) Nitin Khosla et al. MEDICAL CLINICS OF NORTH AMERICA
- Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
- (2009) H.-H. Parving et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review
- (2008) Andrew S. Bomback et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Aliskiren-Binding Increases the Half Life of Renin and Prorenin in Rat Aortic Vascular Smooth Muscle Cells
- (2008) Wendy W. Batenburg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans
- (2008) Naomi D.L. Fisher et al. CIRCULATION
- Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial
- (2008) K. J. Schjoedt et al. DIABETOLOGIA
- Renin-angiotensin system revisited
- (2008) F. Fyhrquist et al. JOURNAL OF INTERNAL MEDICINE
- Update on tissue renin–angiotensin systems
- (2008) Michael Bader et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now